GHK-Cu for hair growth: what the peptide science actually shows

What did @vg48beautypeps actually say?

Honestly? Not much. The transcript from this video is not coherent speech about AHK-Cu or hair growth at all. What was captured reads like song lyrics or garbled audio: "Hold this right through a skin Stand there and love it all But she's gonna teach me how to swim." There is no substantive spoken claim about the peptide, scalp biology, or hair cycling in the transcript itself.

The actual claims in this video come entirely from the caption, which asserts AHK-Cu serum supports "hair growth + thickness" and that "daily scalp care = long-term results." Those are the claims worth examining. The creator does include a disclaimer calling this educational content, not medical advice, which is at least honest framing. But captions still shape what viewers believe, so the science behind those caption claims deserves scrutiny.

Does the science back this up?

There is real, if limited, peer-reviewed support for AHK-Cu's role in hair biology, but the evidence base is narrower than most TikTok content implies. AHK-Cu (alanine-histidine-lysine copper complex) is a synthetic tripeptide that appears to influence hair follicle activity, but calling it a proven hair growth treatment is a stretch based on current data.

A 2018 study by Pickart and Margolina in the journal Biomolecules reviewed copper peptide complexes including GHK-Cu and related compounds, finding they activate hair follicle stem cells and extend the anagen (growth) phase in preclinical models. Separate in vitro research has shown that copper peptides can stimulate follicle dermal papilla cells, which regulate hair cycling. However, most of this work is in cell cultures or animal models. Large, randomized controlled trials in humans specifically on AHK-Cu topical serums for androgenetic alopecia or diffuse thinning are not yet published. The caption's claim about "thickness support" has some biological plausibility, but plausibility is not the same as proven efficacy.

What did they get wrong (or right)?

The caption gets the basic mechanism directionally right: AHK-Cu does interact with scalp tissue in ways that preclinical research links to hair follicle support. That part is not fabricated. Where the content falls short is in the gap between "this peptide has interesting biological activity" and "use this serum for hair growth." Those are very different claims.

The phrase "daily scalp care = long-term results" is vague enough to be technically defensible but functionally misleading. It implies a causal relationship between this specific product and measurable hair outcomes over time. No published human trial on AHK-Cu topical serums has established that equation. The creator also does not acknowledge that hair loss has multiple causes, including hormonal, autoimmune, nutritional, and genetic factors, none of which a peptide serum addresses uniformly. A person with androgenetic alopecia driven by DHT sensitivity is not going to see equivalent results to someone with stress-related telogen effluvium. Lumping all "hair growth journeys" together under one peptide serum narrative is where this content misleads its audience, even if unintentionally.

What should you actually know?

AHK-Cu is a legitimate area of ongoing research, not a fringe compound. It belongs to a family of copper-binding peptides that have shown real activity in wound healing and skin remodeling research. Pickart's work over several decades established that GHK-Cu influences gene expression related to tissue repair, and AHK-Cu shares some structural and functional overlap. That said, "interesting research compound" and "effective hair serum" are separated by a significant clinical evidence gap that has not been closed yet.

If you are experiencing hair loss significant enough to seek treatment, a dermatologist or telehealth provider can assess whether topical minoxidil, oral finasteride, low-level laser therapy, or other interventions with stronger clinical trial data are appropriate for your situation. Peptide-based topicals may eventually earn a stronger evidence base, but right now they are adjuncts at best, not primary treatments. Anyone selling a serum as a standalone solution for hair loss is oversimplifying a complex biological problem.

• AHK-Cu has preclinical support but lacks large-scale human RCT data for hair regrowth specifically.
• Copper peptides generally require consistent, long-term application to show any follicle-level effects, and results vary by cause of hair loss.
• The disclaimer in the caption does not change the implied therapeutic message of the content itself.